Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:classic_Kaposi's_sarcoma
|
gptkbp:associated_with |
gptkb:multicentric_Castleman_disease
gptkb:primary_effusion_lymphoma |
gptkbp:belongs_to |
Herpesviridae family
|
gptkbp:caused_by |
gptkb:healthcare_organization
|
gptkbp:clinical_trial |
considered an oncogenic virus
important in oncology linked to AIDS-related cancers |
gptkbp:discovered_by |
gptkb:1994
|
gptkbp:family |
gptkb:Gammaherpesvirinae
|
gptkbp:genus |
gptkb:Rhadinovirus
|
https://www.w3.org/2000/01/rdf-schema#label |
HHV-8 virus
|
gptkbp:is_known_for |
Kaposi's sarcoma-associated herpesvirus (KSHV)
|
gptkbp:is_protected_by |
safe sex practices
screening blood donors monitoring organ donors |
gptkbp:is_recognized_by |
gptkb:Africa
gptkb:Europe gptkb:Asia gptkb:Italy gptkb:South_America gptkb:United_States |
gptkbp:is_vulnerable_to |
no approved vaccine
|
gptkbp:origin |
endothelial tropism
lymphotropic monocyte tropism |
gptkbp:propagation_method |
organ transplantation
sexual contact blood transfusion |
gptkbp:publishes |
B cells
endothelial cells monocytes |
gptkbp:research_focus |
immune response
vaccine development treatment strategies viral pathogenesis |
gptkbp:seed_dispersal |
double-stranded DNA
approximately 165 kb |
gptkbp:social_responsibility |
serological tests
PCR testing associated with HIV co-infection higher prevalence in sub-Saharan Africa more prevalent in immunocompromised individuals |
gptkbp:symptoms |
weight loss
fever night sweats lymphadenopathy |
gptkbp:treatment |
radiation therapy
chemotherapy antiviral therapy exploring combination therapies investigating novel antiviral agents studying immune modulation therapies |